189 related articles for article (PubMed ID: 8590738)
1. Cell lines for the production of recombinant adeno-associated virus.
Clark KR; Voulgaropoulou F; Fraley DM; Johnson PR
Hum Gene Ther; 1995 Oct; 6(10):1329-41. PubMed ID: 8590738
[TBL] [Abstract][Full Text] [Related]
2. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
3. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
4. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
5. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in recombinant adeno-associated virus vector production.
Clark KR
Kidney Int; 2002 Jan; 61(1 Suppl):S9-15. PubMed ID: 11841606
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
[TBL] [Abstract][Full Text] [Related]
9. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
10. High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus.
Gao GP; Qu G; Faust LZ; Engdahl RK; Xiao W; Hughes JV; Zoltick PW; Wilson JM
Hum Gene Ther; 1998 Nov; 9(16):2353-62. PubMed ID: 9829534
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes.
Qiao C; Li J; Skold A; Zhang X; Xiao X
J Virol; 2002 Feb; 76(4):1904-13. PubMed ID: 11799185
[TBL] [Abstract][Full Text] [Related]
12. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
13. Insect cells as a factory to produce adeno-associated virus type 2 vectors.
Urabe M; Ding C; Kotin RM
Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305
[TBL] [Abstract][Full Text] [Related]
14. Construction of recombinant adeno-associated virus vector containing the rat preproinsulin II gene.
Peng L; Sidner RA; Bochan MR; Burton MM; Cooper ST; Jindal RM
J Surg Res; 1997 Apr; 69(1):193-8. PubMed ID: 9202669
[TBL] [Abstract][Full Text] [Related]
15. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
16. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
17. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
Zhang X; Li CY
Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
[TBL] [Abstract][Full Text] [Related]
18. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
Clark KR; Voulgaropoulou F; Johnson PR
Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
[TBL] [Abstract][Full Text] [Related]
19. Transfer of activation-dependent gene expression into T cell lines by recombinant adeno-associated virus.
Zhang PX; Fuleihan RL
Gene Ther; 1999 Feb; 6(2):182-9. PubMed ID: 10435102
[TBL] [Abstract][Full Text] [Related]
20. Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.
Gao GP; Lu F; Sanmiguel JC; Tran PT; Abbas Z; Lynd KS; Marsh J; Spinner NB; Wilson JM
Mol Ther; 2002 May; 5(5 Pt 1):644-9. PubMed ID: 11991756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
